$0.77
0.0075[0.98%]
At close: Apr 23
$0.77
0[0.00%]
After Hours: 9:24AM EDT
Latest News for Vaxart Stock (NASDAQ:VXRT)
Vaxart Stock (NASDAQ: VXRT)
Categories: All
Thursday, March 14, 2024
Wednesday, March 13, 2024
Wednesday, March 06, 2024
Wednesday, January 31, 2024
- Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Jan 31, 2024, 1:18PM
- Vaxart shares are trading higher after B. Riley Securities upgraded the stock from Neutral to Buy and announced a $2 price target.Benzinga Newsdesk - Jan 31, 2024, 12:45PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Jan 31, 2024, 12:31PM
- B. Riley Securities Upgrades Vaxart to Buy, Announces $2 Price TargetBenzinga Newsdesk - Jan 31, 2024, 9:48AM
Friday, January 19, 2024
Wednesday, January 17, 2024
Tuesday, January 16, 2024
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Jan 16, 2024, 12:31PM
- What's Going On With Vaxart (VXRT) Stock?Henry Khederian - Jan 16, 2024, 10:59AM
- Vaxart shares are trading higher after the company announced it was awarded an ASPR contract by the U.S. government with a total contract value of $9,271,193.Benzinga Newsdesk - Jan 16, 2024, 10:56AM
- UPDATE: On Jan. 12, Vaxart Announced Co Will Receive An Award To Support Clinical Trial Planning Activities For A Phase 2b Clinical Trial That Would Compare The Co's XBB Vaccine Candidate To An mRNA Comparator; Total Contract Value Of $9,271,193.00Benzinga Newsdesk - Jan 16, 2024, 10:36AM
- Vaxart President And CEO Andrei Floroiu Resigns; Chair Michael Finney Assumes Role Of Interim CEOBenzinga Newsdesk - Jan 16, 2024, 9:29AM
- Vaxart Announces $10M Registered Direct Offering With RA Capital Management For Sale Of 15,384,615 Shares At $0.65/ShareBenzinga Newsdesk - Jan 16, 2024, 9:27AM
- Vaxart On Jan. 12, Awarded ASPR Contract By U.S. GovernmentBenzinga Newsdesk - Jan 16, 2024, 9:24AM
Thursday, December 21, 2023
Thursday, November 02, 2023
- Vaxart Q3 EPS $(0.11) Beats $(0.18) Estimate, Sales $2.10M Beat $100.00K EstimateBenzinga Newsdesk - Nov 2, 2023, 4:24PM
- Vaxart Doses First Subject I Phase 1 Trial Of Its Norovirus Vaccine Candidate In Lactating MothersBenzinga Newsdesk - Nov 2, 2023, 8:12AM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM
Wednesday, November 01, 2023
Monday, October 30, 2023
Thursday, September 07, 2023
Monday, August 07, 2023
Thursday, August 03, 2023
Thursday, July 06, 2023
Wednesday, June 07, 2023
- Crude Oil Rises Over 1%; United Natural Foods Posts Downbeat ResultsLisa Levin - Jun 7, 2023, 2:53PM
- Vaxart shares are trading lower after the company announced a $15 million public offering of common stock.Benzinga Newsdesk - Jun 7, 2023, 2:38PM
- Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jun 7, 2023, 2:02PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Jun 7, 2023, 1:31PM
- Nasdaq Drops Over 100 Points; Campbell Soup Earnings Beat EstimatesLisa Levin - Jun 7, 2023, 12:37PM
- Why Vaxart Stock Is Tumbling TodayAdam Eckert - Jun 7, 2023, 10:01AM
- Vaxart Announces Pricing Of $15M Public Offering Of Common StockBenzinga Newsdesk - Jun 7, 2023, 9:17AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jun 7, 2023, 9:06AM
- Why Yext Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving PremarketLisa Levin - Jun 7, 2023, 8:07AM
Tuesday, June 06, 2023
- Vaxart Announces Proposed Public Offering Of Up To Additional 15% Of Common StockBenzinga Newsdesk - Jun 6, 2023, 4:02PM
- Last Subject Completed Dosing In Vaxart's Phase 2 Trial Of Its Oral Pill Bivalent Norovirus Vaccine Candidate. No Vaccine-Related Serious Adverse Events Reported; Topline Data From Two Phase 2 Norovirus Vaccine Studies Expected Over The Next 3 MonthsBenzinga Newsdesk - Jun 6, 2023, 8:08AM